Evolutionary Genomics Inc (FNAM)
0.45
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Evolutionary Genomics PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| June 29, 2020 | 74.37 |
| June 26, 2020 | 74.37 |
| June 25, 2020 | 74.37 |
| June 24, 2020 | 74.37 |
| June 23, 2020 | 74.37 |
| June 22, 2020 | 74.37 |
| June 19, 2020 | 74.37 |
| June 18, 2020 | 74.37 |
| April 29, 2020 | 76.08 |
| April 28, 2020 | 76.08 |
| April 27, 2020 | 76.08 |
| April 24, 2020 | 76.08 |
| April 23, 2020 | 76.08 |
| April 22, 2020 | 76.08 |
| April 21, 2020 | 76.08 |
| April 20, 2020 | 76.08 |
| April 17, 2020 | 76.08 |
| April 16, 2020 | 76.08 |
| April 15, 2020 | 76.08 |
| April 14, 2020 | 76.08 |
| April 13, 2020 | 76.08 |
| April 09, 2020 | 76.08 |
| April 08, 2020 | 76.08 |
| April 07, 2020 | 76.08 |
| April 06, 2020 | 84.09 |
| Date | Value |
|---|---|
| April 03, 2020 | 85.81 |
| April 02, 2020 | 85.81 |
| April 01, 2020 | 85.81 |
| March 31, 2020 | 85.81 |
| March 30, 2020 | 71.91 |
| March 27, 2020 | 95.89 |
| March 26, 2020 | 95.89 |
| March 25, 2020 | 95.89 |
| March 24, 2020 | 95.89 |
| March 23, 2020 | 95.89 |
| March 20, 2020 | 95.89 |
| March 19, 2020 | 95.89 |
| March 18, 2020 | 95.89 |
| March 17, 2020 | 95.89 |
| March 16, 2020 | 95.89 |
| March 13, 2020 | 95.89 |
| March 12, 2020 | 95.89 |
| March 11, 2020 | 95.89 |
| March 10, 2020 | 95.89 |
| March 09, 2020 | 95.89 |
| March 06, 2020 | 95.89 |
| March 05, 2020 | 88.69 |
| March 04, 2020 | 88.69 |
| March 03, 2020 | 88.69 |
| March 02, 2020 | 88.69 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
44.57
Minimum
Sep 12 2019
95.89
Maximum
Mar 06 2020
67.34
Average
60.92
Median
Jun 30 2019
PS Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.031 |
| Palatin Technologies Inc | 3.621 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | 2.767 |
PS Ratio Related Metrics
| Price | 0.45 |
| Market Cap | 2.995M |